Purchases and Sales Made in Q4 2021 in Adverum Biotechnologies, Inc. (ADVM)
This table provides information about the institutional ownership of Adverum Biotechnologies, Inc. (ADVM) during Q4 2021. The information is specifically focused on institutions that hold shares of Adverum Biotechnologies, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2022
Q4 2021
|
Morgan Stanley
New York, NY |
SELL
|
- |
-964K- 66.24% |
$1.68M - $2.31M
|
491K
$2.22M
|
|
|
Feb 14, 2022
Q4 2021
|
Ubs Group Ag
|
SELL
|
- |
-1.01M- 32.16% |
$1.76M - $2.43M
|
2.13M
$9.64M
|
|
|
Feb 01, 2022
Q4 2021
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-1.03M- 70.03% |
$1.79M - $2.47M
|
440K
$1.99M
|
|
|
Feb 11, 2022
Q4 2021
|
K2 Principal Fund, L.P.
Toronto, A6 |
SELL
|
- |
-1.23M- 74.55% |
$2.15M - $2.96M
|
421K
$1.9M
|